NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS

Overview

Journal Acta Endocrinol (Buchar)

Specialty Endocrinology

Date 2019 Jun 1

PMID 31149289

Citations 4

Authors

A Sima

I Sporea

R Timar

M Vlad

A Braha

A Popescu

S Nistorescu

R Mare

R Sirli

A Albai

O Albai

L Diaconu

T Sorescu

S Popescu

L Sima

Affiliations

Soon will be listed here.

Abstract

Context: Nonalcoholic fatty liver disease is common in type 2 diabetes mellitus patients, being difficult to diagnose.

Objective: To find a correlation between elastographic parameters and lab results, for facilitating the diagnosis of nonalcoholic fatty liver disease.

Design: This is a cross sectional study, conducted at the Departments of Diabetes, Nutrition and Metabolic Diseases, and Gastroenterology and Hepatology, of the Clinical Emergency Hospital "Pius Brinzeu" Timisoara.

Subjects And Methods: We included 190 type 2 diabetes mellitus patients, collected data regarding medical history, clinical and biological features and applied the Alcohol Use Disorders Identification Test. We excluded patients with other causes of liver disease. Liver steatosis and fibrosis were evaluated through transient elastography, yielding two parameters: liver stiffness as an indicator of liver fibrosis stage, expressed in kPa, and liver steatosis stage, assessed by controlled attenuation parameter, expressed in dB/m. Data were analyzed using SPSS 15.

Results: The analyzed group comprised 113 patients. Elastographic measurements showed that 93.8% of the patients had steatosis (controlled attenuation parameter ≥232.5 dB/m) and 70.8% severe steatosis (controlled attenuation parameter ≥290 dB/m). Severe steatosis was more common in women (75.7%) than in men (68.1%) (p<0.0001). From the patients with steatosis, 47.2% had liver stiffness values suggestive for fibrosis and 19.8% for cirrhosis. Most patients with steatosis and severe fibrosis were obese (66.7%). Triglycerides/HDLc ratio >4 correlated with hepatic steatosis (p=0.04), being more common in patients with severe fibrosis/cirrhosis (58.3%) than in those with absent or mild fibrosis (36.2%).

Conclusions: Our study found a clear correlation between type 2 diabetes mellitus and the presence of liver steatosis. It correlates with body mass index, waist circumference (in men) and triglycerides/HDLc ratio. Controlled attenuation parameter is a useful noninvasive method for detection and quantification of liver steatosis.

Citing Articles

Safety of SGLT2 Inhibitors and Urinary Tract Infections in Clinical Practice-A Cross-Sectional Study.

Iordan L, Avram V, Timar B, Sturza A, Popescu S, Albai O Medicina (Kaunas). 2025; 60(12.

PMID: 39768854 PMC: 11678545. DOI: 10.3390/medicina60121974.

Predictive Factors for Altered Quality of Life in Patients with Type 2 Diabetes Mellitus.

Albai O, Braha A, Timar B, Timar R J Clin Med. 2024; 13(15).

PMID: 39124656 PMC: 11313388. DOI: 10.3390/jcm13154389.

The epidemiology and characteristics of patients with diabetes with or without NASH: a systematic review.

Aldossari K Afr Health Sci. 2024; 23(2):509-518.

PMID: 38223606 PMC: 10782311. DOI: 10.4314/ahs.v23i2.59.

Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.

Alfadda A, Sherbeeni S, Alqutub A, Aldosary A, Aldaghri N, Taylor-Robinson S Saudi J Gastroenterol. 2022; 28(6):426-433.

PMID: 35645140 PMC: 9843508. DOI: 10.4103/sjg.sjg_73_22.

Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study.

Makker J, Tariq H, Kumar K, Ravi M, Shaikh D, Leung V World J Gastroenterol. 2021; 27(6):523-533.

PMID: 33642826 PMC: 7896434. DOI: 10.3748/wjg.v27.i6.523.

References

Armato J, Reaven G, Ruby R . TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION RATIO IDENTIFIES ACCENTUATED CARDIOMETABOLIC RISK. Endocr Pract. 2015; 21(5):495-500. DOI: 10.4158/EP14479.OR. View

Bertot L, Adams L . The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016; 17(5). PMC: 4881593. DOI: 10.3390/ijms17050774. View

Livadariu R, Timofte D, Trifan A, Danila R, Ionescu L, Singeap A . VITAMIN D DEFICIENCY, A NONINVASIVE MARKER OF STEATOHEPATITIS IN PATIENTS WITH OBESITY AND BIOPSY PROVEN NONALCOHOLIC FATTY LIVER DISEASE. Acta Endocrinol (Buchar). 2019; 14(1):76-84. PMC: 6516593. DOI: 10.4183/aeb.2018.76. View

Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T . Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology. 2005; 41(1):64-71. DOI: 10.1002/hep.20543. View

Ahmed M . Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015; 7(11):1450-9. PMC: 4462685. DOI: 10.4254/wjh.v7.i11.1450. View

Doycheva I, Patel N, Peterson M, Loomba R . Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications. 2013; 27(3):293-300. PMC: 4167586. DOI: 10.1016/j.jdiacomp.2012.10.008. View

Shi K, Tang J, Zhu X, Ying L, Li D, Gao J . Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol. 2014; 29(6):1149-58. DOI: 10.1111/jgh.12519. View

Adams L, Angulo P, Lindor K . Nonalcoholic fatty liver disease. CMAJ. 2005; 172(7):899-905. PMC: 554876. DOI: 10.1503/cmaj.045232. View

Caldwell S . Cryptogenic cirrhosis: what are we missing?. Curr Gastroenterol Rep. 2010; 12(1):40-8. DOI: 10.1007/s11894-009-0082-7. View

10.

Clark J . The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006; 40 Suppl 1:S5-10. DOI: 10.1097/01.mcg.0000168638.84840.ff. View

11.

Ekstedt M, Franzen L, Mathiesen U, Thorelius L, Holmqvist M, Bodemar G . Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44(4):865-73. DOI: 10.1002/hep.21327. View

12.

Kim-Dorner S, Deuster P, Zeno S, Remaley A, Poth M . Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?. Metabolism. 2009; 59(2):299-304. DOI: 10.1016/j.metabol.2009.07.027. View

13.

Stepanova M, Aquino R, Alsheddi A, Gupta R, Fang Y, Younossi Z . Clinical predictors of fibrosis in patients with chronic liver disease. Aliment Pharmacol Ther. 2010; 31(10):1085-94. DOI: 10.1111/j.1365-2036.2010.04266.x. View

14.

Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S . The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006; 38(7):485-9. DOI: 10.1016/j.dld.2006.03.021. View

15.

Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K . The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998; 158(16):1789-95. DOI: 10.1001/archinte.158.16.1789. View

16.

Myers R, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M . Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012; 32(6):902-10. DOI: 10.1111/j.1478-3231.2012.02781.x. View

17.

Neuschwander-Tetri B, Clark J, Bass N, Van Natta M, Unalp-Arida A, Tonascia J . Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010; 52(3):913-24. PMC: 3070295. DOI: 10.1002/hep.23784. View

18.

Da Luz P, Favarato D, Faria-Neto Jr J, Lemos P, Chagas A . High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo). 2008; 63(4):427-32. PMC: 2664115. DOI: 10.1590/s1807-59322008000400003. View

19.

. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016; 64(6):1388-402. DOI: 10.1016/j.jhep.2015.11.004. View

20.

Lupsor-Platon M, Feier D, Stefanescu H, Tamas A, Botan E, Sparchez Z . Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study. J Gastrointestin Liver Dis. 2015; 24(1):35-42. DOI: 10.15403/jgld.2014.1121.mlp. View